Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-01-12 Sale |
2021-01-14 4:05 pm |
Homology Medicines Inc. | FIXX | Kelly Timothy P See Remarks |
500 | $13 | $6,500 | 45,000 (Direct) |
View |
2021-01-06 Sale |
2021-01-08 4:05 pm |
Homology Medicines Inc. | FIXX | Seymour Albert Chief Scientific Officer |
15,000 | $12.06 | $180,865 | 129,017 (Direct) |
View |
2021-01-05 Sale |
2021-01-07 4:05 pm |
Homology Medicines Inc. | FIXX | Seymour Albert Chief Scientific Officer |
10,000 | $11.44 | $114,422 | 144,017 (Direct) |
View |
2021-01-04 Sale |
2021-01-06 4:05 pm |
Homology Medicines Inc. | FIXX | Kelly Timothy P See Remarks |
4,000 | $11.5 | $45,983 | 81,501 (Direct) |
View |
2020-12-22 Sale |
2020-12-28 9:37 pm |
Homology Medicines Inc. | FIXX | PARMAR KUSH Director |
500,000 | $12.82 | $6,410,000 | 181,435 (Indirect) |
View |
2020-12-22 Sale |
2020-12-28 9:35 pm |
Homology Medicines Inc. | FIXX | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
500,000 | $12.82 | $6,410,000 | 181,435 (Indirect) |
View |
2020-12-14 Sale |
2020-12-16 7:25 pm |
Homology Medicines Inc. | FIXX | PARMAR KUSH Director |
500,000 | $12.25 | $6,125,915 | 201,435 (Indirect) |
View |
2020-12-14 Sale |
2020-12-16 7:15 pm |
Homology Medicines Inc. | FIXX | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
500,000 | $12.25 | $6,125,915 | 201,435 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-01-12 Exercise |
2021-01-14 4:05 pm |
N/A 2027-12-06 |
Homology Medicines Inc. | FIXX | Kelly Timothy P See Remarks |
500 | $0 | 45,000 (Direct) |
View |
2021-01-12 Exercise |
2021-01-14 4:05 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Kelly Timothy P See Remarks |
500 | $6.6314 | 45,000 (Direct) |
View |
2021-01-04 Exercise |
2021-01-06 4:05 pm |
N/A 2027-12-06 |
Homology Medicines Inc. | FIXX | Kelly Timothy P See Remarks |
4,000 | $0 | 81,501 (Direct) |
View |
2021-01-04 Exercise |
2021-01-06 4:05 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Kelly Timothy P See Remarks |
2,000 | $2.8947 | 81,501 (Direct) |
View |
2021-01-04 Exercise |
2021-01-06 4:05 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Kelly Timothy P See Remarks |
2,000 | $6.6314 | 81,501 (Direct) |
View |
2020-07-21 Option Award |
2020-07-21 5:31 pm |
N/A 2030-07-20 |
Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director |
36,000 | $0 | 36,000 (Direct) |
View |
2020-06-10 Option Award |
2020-06-12 5:33 pm |
N/A 2030-06-10 |
Homology Medicines Inc. | FIXX | REICIN ALISE Director |
18,000 | $0 | 18,000 (Direct) |
View |
2020-06-10 Option Award |
2020-06-12 5:31 pm |
N/A 2030-06-10 |
Homology Medicines Inc. | FIXX | PARMAR KUSH Director 10% Owner |
18,000 | $0 | 18,000 (Direct) |
View |
2020-06-10 Option Award |
2020-06-12 5:27 pm |
N/A 2030-06-10 |
Homology Medicines Inc. | FIXX | Gregory Richard J. Director |
18,000 | $0 | 18,000 (Direct) |
View |
2020-06-10 Option Award |
2020-06-12 5:27 pm |
N/A 2030-06-10 |
Homology Medicines Inc. | FIXX | Thistle Mary Director |
18,000 | $0 | 18,000 (Direct) |
View |
2020-06-10 Option Award |
2020-06-12 5:27 pm |
N/A 2030-06-10 |
Homology Medicines Inc. | FIXX | Patterson Matthew R Director |
18,000 | $0 | 18,000 (Direct) |
View |
2020-06-10 Option Award |
2020-06-12 5:25 pm |
N/A 2030-06-10 |
Homology Medicines Inc. | FIXX | GILLIS STEVEN Director |
18,000 | $0 | 18,000 (Direct) |
View |